Rakesh Jain PhD, Director of the E.L. Steele Laboratories for Tumor Biology at Massachusetts General Hospital and A. Werk ...

MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...

Are you searching for effective medications to treat 'Leukemia'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for 'managing ...

New research published today in Nature identifies a pathway that keeps the cancer cells alive long enough to evolve such resistance, and shows that inhibiting this pathway in mice with acute ...

KU School of Medicine-Wichita Department of Pediatrics and Wesley Children’s Hospital say a groundbreaking treatment for ...

Targeted therapies for high-risk leukemia in children have yet to be developed, but scientists at Université de Montréal and ...

A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations.

The China-based drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is ...

The investigators subsequently demonstrated positive results in leukemia models, finding that the nanoparticles were more effective at shrinking tumors when compared with the drugs alone.